Skip to main content
Clinical Trials/NCT07319390
NCT07319390
Completed
Not Applicable

Midpoint Transverse Process to Pleura Block vs Erector Spinae Plane Block for Postoperative Analgesia in Laparoscopic Sleeve Gastrectomy

Ain Shams University1 site in 1 country52 target enrollmentStarted: October 3, 2025Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
52
Locations
1
Primary Endpoint
Mean postoperative pain numeric rating scale

Overview

Brief Summary

The aim of this study will be to compare between MTP and ESPB in terms of postoperative pain score in patients undergoing laparoscopic sleeve gastrectomy

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Double (Participant, Outcomes Assessor)

Masking Description

the patient and data collector won't know type of the block received

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Anesthesiologists (ASA) physical status II, of either sex Age ≥18 y.
  • Undergoing laparoscopic sleeve gastrectomy

Exclusion Criteria

  • Patient refusal to give consent for the block
  • Hypersensitivity to any of study medications
  • Infection at site of the block
  • Coagulopathy
  • severe cardiac/hepatic/renal disease

Arms & Interventions

Group A (ESPB): Bilateral ESP

Active Comparator

block at T7 with 20 mL of 0.25% bupivacaine on each side

Intervention: Erector Spinae Plane Block (ESPB) group (Procedure)

Group B (MTPB): Bilateral MTP

Active Comparator

block at T7 with 20 mL of 0.25% bupivacaine on each side

Intervention: Midpoint Transverse Process to Pleura Block (MTPPB) (Procedure)

Outcomes

Primary Outcomes

Mean postoperative pain numeric rating scale

Time Frame: pain will be evaluated first in postanesthesia care unit then at 1, 3, 6, 8, 12, 18, 24 hours posoperative

Abdominal pain will be assessed using numeric rating scale which includes 10 degrees of which zero is no pain and 10 is maximum pain ever

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials